Piperacillin/tazobactam versus cefepime as initial empirical antimicrobial therapy in febrile neutropenic patients: a prospective randomized pilot study.

European journal of medical research

Volumn 3, Issue 7, 1998, Pages 324-330

  Bohme A ^a   Shah, P M ^a   Stille, W ^a   Hoelzer, D ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEFEPIME; CEPHALOSPORIN DERIVATIVE; DRUG DERIVATIVE; PENICILLANIC ACID; PIPERACILLIN; TAZOBACTAM;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; FEVER; HUMAN; NEUTROPENIA; PILOT STUDY; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ANTI-INFECTIVE AGENTS; CEPHALOSPORINS; DRUG THERAPY, COMBINATION; FEVER; HUMANS; NEUTROPENIA; PENICILLANIC ACID; PILOT PROJECTS; PIPERACILLIN; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 0032551404     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)